112 related articles for article (PubMed ID: 30017597)
1. Sustained Remission of γδ T-Cell Lymphoma by Graft-Versus-Lymphoma Effect That Relapsed Early After Cord Blood Transplantation.
Ichikawa S; Fukuhara N; Onishi Y; Ichinohasama R; Harigae H
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e369-e372. PubMed ID: 30017597
[No Abstract] [Full Text] [Related]
2. Durable remission in a patient with refractory subcutaneous panniculitis-like T-cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation through withdrawal of cyclosporine.
Yuan L; Sun L; Bo J; Zhou Y; Li HH; Yu L; Gao CJ
Ann Transplant; 2011; 16(3):135-8. PubMed ID: 21959522
[TBL] [Abstract][Full Text] [Related]
3. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplant following chemotherapy containing l-asparaginase as a promising treatment for patients with relapsed or refractory extranodal natural killer/T cell lymphoma, nasal type.
Yokoyama H; Yamamoto J; Tohmiya Y; Yamada MF; Ohguchi H; Ohnishi Y; Okitsu Y; Fukuhara N; Ohba-Ohtsuka R; Kohata K; Ishizawa K; Kameoka J; Harigae H
Leuk Lymphoma; 2010 Aug; 51(8):1509-12. PubMed ID: 20496989
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of advanced extranodal NK/T cell lymphoma with unrelated cord blood transplantation.
Yokoyama H; Yamada MF; Ishizawa K; Yamamoto J; Tomiya Y; Harigae H; Kameoka J; Ichinohasama R; Sasaki T
Tohoku J Exp Med; 2007 Apr; 211(4):395-9. PubMed ID: 17409680
[TBL] [Abstract][Full Text] [Related]
6. Successful unrelated cord blood transplantation following reduced-intensity conditioning for refractory acute myeloid leukemia.
Berger M; Vassallo E; Nesi F; Venturi C; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2004 Feb; 26(2):98-100. PubMed ID: 14767195
[TBL] [Abstract][Full Text] [Related]
7. A type of rat hepatosplenic gamma-delta (gammadalta) T-cell lymphoma developed after injections with hepatocyte growth factor (HGF) oligonucleotides, which was rejected by surviving syngeneic spleen graft.
Nakatsuji T
Leuk Lymphoma; 2003 Jan; 44(1):175-81. PubMed ID: 12691160
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of relapsed blastic natural killer cell lymphoma with unrelated cord blood transplantation.
Yoshimasu T; Manabe A; Tanaka R; Mochizuki S; Ebihara Y; Ishikawa K; Iseki T; Oyaizu N; Aritaki K; Tanaka K; Tsuruta T; Hoshika A; Asano S; Tsuji K
Bone Marrow Transplant; 2002 Jul; 30(1):41-4. PubMed ID: 12105776
[TBL] [Abstract][Full Text] [Related]
9. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation.
Sakai R; Fujisawa S; Fujimaki K; Kanamori H; Ishigatsubo Y
Bone Marrow Transplant; 2006 Mar; 37(5):537-8. PubMed ID: 16415891
[No Abstract] [Full Text] [Related]
10. Impact of pretransplant minimal residual disease after cord blood transplantation for childhood acute lymphoblastic leukemia in remission: an Eurocord, PDWP-EBMT analysis.
Ruggeri A; Michel G; Dalle JH; Caniglia M; Locatelli F; Campos A; de Heredia CD; Mohty M; Hurtado JM; Bierings M; Bittencourt H; Mauad M; Purtill D; Cunha R; Kabbara N; Gluckman E; Labopin M; Peters C; Rocha V
Leukemia; 2012 Dec; 26(12):2455-61. PubMed ID: 22555150
[TBL] [Abstract][Full Text] [Related]
11. Successful allogeneic bone marrow transplantation for hepatosplenic gammadelta T cell lymphoma.
Ooi J; Iseki T; Adachi D; Yamashita T; Tomonari A; Tojo A; Tani K; Asano S
Haematologica; 2001 Oct; 86(10):E25. PubMed ID: 11602432
[No Abstract] [Full Text] [Related]
12. Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma.
Sumi M; Takeda W; Kaiume H; Kirihara T; Kurihara T; Sato K; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Kobayashi H
Leuk Lymphoma; 2015 Apr; 56(4):1140-2. PubMed ID: 25065703
[No Abstract] [Full Text] [Related]
13. Early central nervous system relapse of monomorphic epitheliotropic intestinal T-cell lymphoma after cord blood transplantation.
Nato Y; Miyazaki K; Imai H; Nakano E; Kageyama Y; Ino K; Fujieda A; Matsumoto T; Tawara I; Tanaka K; Yamaguchi M; Katayama N
Int J Hematol; 2021 Jul; 114(1):129-135. PubMed ID: 33646526
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma.
He S; Roberts A; Ritchie D; Grigg A
Leuk Lymphoma; 2007 Jul; 48(7):1448-50. PubMed ID: 17613781
[No Abstract] [Full Text] [Related]
16. Gamma delta T cell reconstitution is associated with fewer infections and improved event-free survival after hematopoietic stem cell transplantation for pediatric leukemia.
Perko R; Kang G; Sunkara A; Leung W; Thomas PG; Dallas MH
Biol Blood Marrow Transplant; 2015 Jan; 21(1):130-6. PubMed ID: 25445640
[TBL] [Abstract][Full Text] [Related]
17. [Graft-versus-leukemia effect by lymphocytes from the first donor after second cord blood transplantation in a patient with T-lymphoblastic lymphoma].
Nagai K; Hashimoto H; Itoh K; Matsushita A; Shimoji S; Kimura T; Inoue D; Mori M; Nagai Y; Tabata S; Yanagida M; Takahashi T
Rinsho Ketsueki; 2010 Jun; 51(6):413-21. PubMed ID: 20622488
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis.
Ustun C; Giannotti F; Zhang MJ; Wang HL; Brunstein C; Labopin M; Rocha V; de Lima M; Baron F; Sandmaier BM; Eapen M; Gluckman E; Nagler A; Weisdorf DJ; Ruggeri A
Leukemia; 2017 Jun; 31(6):1408-1414. PubMed ID: 28119528
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.
Ueki T; Sumi M; Sato K; Shimizu I; Akahane D; Ueno M; Ichikawa N; Nakao S; Kobayashi H
Eur J Haematol; 2011 Mar; 86(3):268-71. PubMed ID: 21114536
[No Abstract] [Full Text] [Related]
20. Induction of graft-versus-host disease and a graft-versus-leukemia effect using ubenimex in a patient with infantile leukemia relapsing after an unrelated cord blood transplant.
Okada H; Nomi K; Hamatani S; Kuromi T; Nanba M; Imai T; Isobe K; Itoh S
Bone Marrow Transplant; 2002 Oct; 30(7):463-5. PubMed ID: 12368960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
